Related Experiment Video
Updated: Feb 14, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Plasma adrenomedullin level in children with obesity: relationship to left ventricular function
Kotb Abbass Metwalley1, Hekma Saad Farghaly2, Tahra Sherief3
1Pediatric Endocrinology Unit, Department of Pediatrics, Faculty of Medicine, Assiut University, B.O, Assiut, 71111, Egypt. kotb72@gmail.com.
Insights
Elevated adrenomedullin (AM) levels in obese children correlate with cardiac hypertrophy and dysfunction. Measuring AM may help identify children at high risk for developing left ventricular hypertrophy.
Area of Science:
- Pediatric Cardiology
- Endocrinology
- Biomarker Research
Background:
- Obesity in children is linked to increased risk of abnormal cardiac structure and function.
- Adrenomedullin (AM), a cytokine, is explored as a potential biomarker for cardiac hypertrophy in obese children.
- Limited knowledge exists regarding AM's role in pediatric obesity-related cardiac changes.
Purpose of the Study:
- To assess plasma AM levels in obese children.
- To investigate the relationship between AM levels and left ventricular (LV) functions in this cohort.
- To determine if AM can serve as a biomarker for LV hypertrophy in obese children.
Main Methods:
- A cohort of 60 obese children and 60 non-obese controls were studied.
- Measurements included blood pressure, lipid profile, glucose, insulin, HOMA-IR, and plasma AM.
- Echocardiography was used to assess cardiac dimensions and LV functions.
Main Results:
- Obese children exhibited higher blood pressure, insulin, HOMA-IR, and AM levels compared to controls.
- Obese children showed signs of LV hypertrophy (increased LVMI) and diastolic dysfunction.
- Plasma AM levels positively correlated with LVMI and mitral deceleration time in obese children with LV hypertrophy.
Conclusions:
- Plasma AM levels are elevated in obese children, especially those with LV hypertrophy.
- AM levels correlate with increased blood pressure and insulin resistance.
- Plasma AM measurement can aid in identifying obese children at risk for LV hypertrophy and dysfunction.
Background:
Obese children are at increased risk for abnormal cardiac structure and function. Little is known about adrenomedullin (AM), a cytokine produced in various organs and tissues, as a biomarker of cardiac hypertrophy in obese children. This study aimed to assess the plasma AM levels in a cohort of obese children and its relationship to left ventricular (LV) functions.
Methods:
The study included 60 obese children and 60 non-obese children matched for age and gender as control group. Blood pressure, serum lipid profile, fasting glucose, insulin and plasma AM and the homeostatic model assessment of insulin resistance (HOMA-IR) were measured. Cardiac dimensions and LV functions were assessed using conventional echocardiography.
Results:
Compared to control subjects, obese children had higher blood pressure (P = 0.01), insulin (P = 0.001), HOMA-IR (P = 0.001), and AM (P = 0.001). Moreover, obese children had higher LV mass index (LVMI) (P = 0.001), indicating LV hypertrophy; prolonged isovolumic relaxation times (P = 0.01), prolonged mitral deceleration time (DcT) (P = 0.01) and reduced ratio of mitral E-to-mitral A-wave peak velocity (P = 0.01), indicating LV diastolic dysfunction. Laboratory abnormalities were only present in children with LV hypertrophy. In multivariate analysis in obese children with LV hypertrophy, AM levels were positively correlated with LVMI [odds ratio (OR) 1.14, 95% confidence interval (Cl) 1.08-1.13, P = 0.0001] and mitral DcT (OR 2.25, 95% CI 1.15-2.05, P = 0.01) in the presence of higher blood pressure and HOMA-IR. A cut-off value of AM at 52 pg/mL could differentiate obese children with and without left ventricular hypertrophy at a sensitivity of 94.32% and specificity of 92.45%.
Conclusions:
Plasma AM levels may be elevated in obese children particularly those with LV hypertrophy and is correlated with higher blood pressure and insulin resistance. Measurement of plasma AM levels in obese children may help to identify those at high risk of developing LV hypertrophy and dysfunction.
More Related Videos
Related Concept Videos
Obesity
Relationship Formation
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Ending Relationships
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Relationship Growth

